Reminder: Invitation to Roche ’s virtual event on key neuromuscular data presented at the 2022 Muscular Dystrophy Association (MDA) scientific and clinical conference

 We are pleased to invite investors and analysts to participate in our virtual event onWednesday, 16 March 2022, highlighting Roche data presented during the 2022 Muscular Dystrophy Association - MDA -Virtual Clinical and Scientific Conference, from 13th to 16th March.16:30 – 17:30 CET / 15:30 - 16:30 GMT11:30 – 12:30 am EDT / 8:30 – 9:30 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available fordownload at15:30 CET on the day of the event.>click here AgendaWelcomeBruno Eschli, Head of Investor Relations Neuromuscular franchise strategySamir Megateli, Global Franchise Head, Neuromuscular Diseases, Global Product Strategy Key Data at MDA 2022Kathryn Wagner, Vice President and Global Head Neuromuscular, Clinical Development Q&A Access to virtual event (pre-registration required)Please pre-register for our webinarhere*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail]. A replay of the webcast will be available via>ir.roche.com *privacy notice Best regards, Bruno EschliHead of Investor RelationsGerard TobinInvestor Relations Officer Roche Investor Relations Dr. Karl MahlerPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPhone: [phone]e-mail:[e-mail] Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Birgit M...

Source: Roche Investor Update - March 9, 2022 Category: Pharmaceuticals Source Type: news